Latest Senate FDA Reform Bill Would Delay Guidance On Mobile Health Apps
This article was originally published in The Gray Sheet
The Senate user fee reauthorization and FDA reform bill, formally introduced May 15, includes several new provisions, including a moratorium on FDA issuing final guidance on mobile medical apps. The bill should see action on the Senate floor this week.
You may also be interested in...
FDA plans to release guidance for mobile medical apps ahead of a larger regulatory framework on health information technology, according to an agency official.
The legislation, awaiting the signature of the president, will bring greater scrutiny of device center activities by Congress and industry.
Pfizer and Sanofi representatives discuss how pharmaceutical firms can best leverage mobile platforms to reach consumers. Elements to consider include ensuring a mobile website makes a good first impression, delivering a message that is simple and on-point, integrating the mobile platform strategy with the brand strategy and considering how best to use tools like text messaging and apps.